[Intravitreal triamcinolone acetonide treatment in diabetic macular edema].
To assess the efficacy and safety of intravitreal triamcinolone acetonide in diabetic macular oedema. prospective study; 76 patients, 102 eyes; preoperative assessment: visual acuity, intraocular pressure, fundus biomicroscopy fluoresceine angiography, sometimes OCT; postoperative assessment: visual acuity, intraocular pressure, fundus biomicroscopy, fluoresceine angiography, sometimes OCT. Visual acuity improvement in 42% cases; subjective improvement of visual acuity in 72% of cases Triamcinolon acetonide may play a role in treatment of diabetic macular oedema.